Cargando…

MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function

Cuproptosis caused by copper overload is mediated by a novel regulatory mechanism that differs from previously documented mechanisms regulating cell death. Cells dependent on mitochondrial respiration showed increased sensitivity to a copper ionophore elesclomol that induced cuproptosis. Maternal em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhipeng, Zhou, Huaxin, Zhai, Xiangyu, Gao, Lin, Yang, Mengfan, An, Baokun, Xia, Tong, Du, Gang, Li, Xiaoming, Wang, Wei, Jin, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638394/ https://www.ncbi.nlm.nih.gov/pubmed/37949877 http://dx.doi.org/10.1038/s41419-023-06264-3

Ejemplares similares

Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker
por: Xu, Lidong, et al.
Publicado: (2023)

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients
por: Bai, Wen Dong, et al.
Publicado: (2022)

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
por: Zhang, Xiaoling, et al.
Publicado: (2023)

PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
por: Chen, Qianqian, et al.
Publicado: (2022)

Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy
por: Yang, Qinjing, et al.
Publicado: (2023)

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
por: Huang, Shuaishuai, et al.
Publicado: (2023)

HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
por: Li, Zhipeng, et al.
Publicado: (2023)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis
por: Fang, Zengli, et al.
Publicado: (2023)

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance
por: Zhai, Xiangyu, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
por: Wang, Huihui, et al.
Publicado: (2023)

Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation
por: Zhao, Zizuo, et al.
Publicado: (2023)

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
por: Wang, Hongjin, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC
por: Qin, Haotian, et al.
Publicado: (2023)

DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases
por: Zhang, Peng, et al.
Publicado: (2023)

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2015)

Comprehensive Analysis of Cuproptosis Genes and Identification of Cuproptosis Subtypes in Breast Cancer
por: Li, Jialin, et al.
Publicado: (2023)

Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2018)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science
por: Ibanez, Agustin, et al.
Publicado: (2021)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

MELK is not necessary for the proliferation of basal-like breast cancer cells
por: Huang, Hai-Tsang, et al.
Publicado: (2017)

Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition
por: Li, Bo, et al.
Publicado: (2021)

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2014)

MELK—a conserved kinase: functions, signaling, cancer, and controversy
por: Ganguly, Ranjit, et al.
Publicado: (2015)

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2016)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
por: Wang, Yubao, et al.
Publicado: (2018)

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
por: Lin, Meng-Lay, et al.
Publicado: (2007)

Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2018)

Laparoscopic vs. open anatomical hepatectomy for intrahepatic cholangiocarcinoma: A retrospective cohort study
por: Wang, Jianlei, et al.
Publicado: (2022)

A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
por: Zhu, HuaXin, et al.
Publicado: (2022)

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
por: Pickard, Mark R, et al.
Publicado: (2009)

MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_30c6b43f9q8g8b0lsjs16a9fvk